ABSTRACT Airway hyperresponsiveness is a major characteristic of asthma and is believed to result from the excessive contraction of airway smooth muscle cells (SMCs). However, the identification of the mechanisms responsible for airway hyperresponsiveness is hindered by our limited understanding of how calcium (Ca 21 ), myosin light chain kinase (MLCK), and myosin light chain phosphatase (MLCP) interact to regulate airway SMC contraction. In this work, we present a modified Hai-Murphy cross-bridge model of SMC contraction that incorporates Ca 21 regulation of MLCK and MLCP. A comparative fit of the model simulations to experimental data predicts 1), that airway and arteriole SMC contraction is initiated by fast activation by Ca 21 of MLCK; 2), that airway SMC, but not arteriole SMC, is inhibited by a slower activation by Ca 21 of MLCP; and 3), that the presence of a contractile agonist inhibits MLCP to enhance the Ca 21 sensitivity of airway and arteriole SMCs. The implication of these findings is that murine airway SMCs exploit a Ca 21 -dependent mechanism to favor a default state of relaxation. The rate of SMC relaxation is determined principally by the rate of release of the latch-bridge state, which is predicted to be faster in airway than in arteriole. In addition, the model also predicts that oscillations in calcium concentration, commonly observed during agonist-induced smooth muscle contraction, cause a significantly greater contraction than an elevated steady calcium concentration.
INTRODUCTION
Airway hyperresponsiveness is a characteristic of asthma and is generally ascribed to the excessive contraction of airway smooth muscle cells (SMCs). Although individual cells may generate more force, this change may also occur because of an increase in SMC mass, an increased sensitivity to agonists, or a reduction in elastic recoil forces (1) . To determine the role of the individual SMC in airway hyperresponsiveness, we focused on the cellular mechanisms that regulate and produce airway SMC contraction.
Airway SMC contraction is initiated by a rise in intracellular Ca 21 concentration ([Ca 21 ] i ), which, in turn, sequentially activates Ca 21 -calmodulin and myosin light chain kinase (MLCK). MLCK phosphorylates the regulatory light chain of myosin (rMLC), allowing myosin to enter the crossbridge cycle with actin to generate a sliding force to contract the SMC. Relaxation of the SMCs essentially requires a decrease in [Ca 21 ] i , but the extending force is passive and is provided by the elastic recoil of the lung parenchyma coupled with breathing.
Although this basic idea of airway SMC contraction is well accepted, there are a number of important processes that have major implications for the regulation of SMC contractility. First, in normal airway and arteriole SMCs, the increase in [Ca 21 ] i does not occur as a uniform steady-state increase but occurs as a series of oscillatory Ca 21 waves that propagate along the SMCs (2) (3) (4) (5) . Second, the contractile sensitivity of the SMCs to [Ca 21 ] i can be substantially regulated by the stimulating agonist (6) . Third, and perhaps the most unexpected specialization of mouse airway SMCs, sustained elevated [Ca 21 ] i induces airway relaxation (5) . Although the Ca 21 oscillations initiate contraction, it is the relative Ca 21 -dependent activities of MLCK and myosin light chain phosphatase (MLCP) that determine the sustained contractile state.
In normal mouse lung slices, the addition of agonists initiates contraction of the airways (MCh and 5-HT) and arterioles (5-HT only) by initiating Ca 21 oscillations in the SMCs (3, 4) . However, to determine the contribution of Ca 21 sensitization to the contractile state, it is necessary to maintain the [Ca 21 ] i at a steady state. This was achieved by simultaneously treating the lung slices with caffeine and ryanodine. Caffeine activates the ryanodine receptor, allowing ryanodine access to lock the ryanodine receptor in an open state. This treatment results in emptying the internal Ca 21 stores of the airway and arteriole SMCs, which leads to a sustained influx of Ca 21 , presumably via store-operated channels. By varying the external calcium concentration, the internal [Ca 21 ] i of the SMCs can be experimentally clamped. As expected with this caffeine-ryanodine treated lung slice, [Ca 21 ] i -induced contraction increases in both the airway and arteriole SMCs. The first key result was that in the presence of this sustained increase in [Ca 21 ] i , the airway SMCs subsequently relaxed (Fig. 1) . However, under identical conditions, the adjacent arteriole SMCs remained contracted ( Fig. 1) . To explain this Ca 21 -induced airway relaxation, we hypothesized that the increase in [Ca 21 ] i activates airway MLCP (either directly or indirectly) on a relatively slow timescale, compared to the Ca 21 activation of MLCK, to reduce rMLC phosphorylation and hence force production. By contrast, we proposed the arteriole MLCP to be insensitive to Ca 21 . The second key result was that upon the subsequent exposure to a contractile agonist (5-HT), the relaxed airway recontracted whereas the arteriole displayed a further contraction even though the [Ca 21 ] i in either SMC type remained high and unchanged (Fig. 1) . Therefore, we proposed that the agonist also stimulates a Ca 21 -independent inhibition of MLCP (in both the airway and arteriole) to enhance force production.
Here we develop a mathematical model to analyze how the Ca 21 -and agonist-dependent activity of the MLKC and MLCP are responsible for the final rMLC phosphorylation and SMC contraction. The model is based on the experimental responses of airway and arteriole SMCs in lung slices under steady-state Ca 21 conditions and explicitly considers the length changes of SMCs during contraction. Because the agonist simultaneously stimulates both Ca 21 oscillations and increases in Ca 21 sensitivity, it is difficult to determine experimentally the relative importance of each mechanism in the regulation of SMC contraction and how these may be altered to result in hyperresponsiveness. Consequently, we used the model to evaluate the influence of Ca 21 oscillations on airway and arteriole SMC. Previous mathematical models have concentrated on airway SMC. They relied on force generation data of isolated SMCs under isometric conditions or measurement of the resistance of the whole airway and did not include the regulation of MLCP (7) (8) (9) (10) (11) (12) (13) .
THE MODEL
To understand the complex dynamics of SMC contraction, we expanded the Hai-Murphy cross-bridge model (7) to include Ca 21 activation of MLCK, Ca 21 activation of MLCP, and agonist inactivation of MLCP. Our model is based on the modification of the Hai-Murphy cross-bridge model by Mijailovich et al. (7) (8) (9) (10) (11) . A schematic diagram of the crossbridge model is shown in Fig. 2 . The key parameters of this FIGURE 1 Response of an airway and arteriole in a lung slice to agonist and high [Ca 21 ] i . The experimental data show the simultaneous changes in airway and arteriole lumen size in response to 5-HT or changes in extracellular Ca 21 and were obtained using the methods detailed in Bai and Sanderson (5) . Normal airways and arterioles were contracted with 1 mM 5-HT. The same lung slice was subsequently treated with caffeine (20 mM) and ryanodine (50 mM) for 5 min to allow the [Ca 21 ] i to be experimentally altered. The caffeine and ryanodine were removed by washing, and the lung slice was equilibrated with zero external Ca 21 . The ) raises internal Ca 21 and induces contraction of both the airway and arteriole. However, the airway relaxes, whereas the arteriole continues to contract to reach a steady state. Upon the addition of agonist, the airway fully recontracts (similar to the normal slice), whereas the arteriole displays a further contraction. Removal of the agonist allows the relaxation of both airway and arteriole even though the [Ca 21 ] i remains high. Removal of extracellular Ca 21 allows the arteriole to fully relax. FIGURE 2 Schematic diagram of the model. M denotes myosin, AM denotes myosin attached to actin, and a subscript p denotes the phosphorylated state of the rMLC. Active force generation results from cycling between M p and AM p . However, cycling cross-bridges can be dephosphorylated into the latch state, AM, where they can neither exert active force nor relax quickly. We assume that the rate of phosphorylation of myosin is unaffected by its attachment to actin. k 1 is the rate of M and AM phosphorylation by MLCK, and k 2 is the rate of M and AM dephosphorylation by MLCP. The rate constants f p (x), g p (x), and g(x) are position dependent, as described in The Model. model relevant to our experimental data are k 1 , the rate of rMLC phosphorylation by MLCK, and k 2 , the rate of rMLC dephosphorylation by MLCP. Both are assumed independent of whether or not the myosin is attached to actin (8) . 
where
and t p is a time constant. The exponent 2 in Eq. 2 was chosen to give good agreement with experimental data; an exponent of 1 did not fit the data as well (sum of squared residuals 1.5 and 4.3, respectively, F-ratio test p , 0.01). Since the mechanisms of agonist-induced Ca 21 sensitization (or inhibition of MLCP) are not fully understood and can vary with the agonist, tissue, and SMC type (14) , we adopted the strategy of omitting the detailed reactions and assuming simple direct relationships with plausible functional forms. Thus, for example, the activation of MLCP is assumed to depend directly on the calcium concentration, c, not on the concentration of calcium/calmodulin or through any other intermediate reactions. Consequently, we used a Hill function to model a generic increasing dependence on c. Similarly, inactivation of MLCP by agonist is assumed to depend directly on the agonist concentration, even though this is a drastic simplification. We are aware that there are a number of possible intermediate reactions between the agonist and its effect on MLCP, but for this model it suffices to assume that the rate of inactivation of MLCP is an increasing function of the agonist concentration, a.
The cross-bridge model
The attachment of myosin to actin depends on its phosphorylated state and its position with respect to the binding site on the actin filament. We denote by the local coordinate x the distance between the binding site on the actin filament and the equilibrium position of the cross-bridge. The distribution of cross-bridges at x is determined by
subject to the constraint
is the velocity of the actin filament relative to the myosin filament, defined to be positive during shortening. The rate constants f p (x), g p (x), and g(x) are based on Mijailovich et al. (8):
x . h;
where h, the largest displacement at which a cross-bridge can become attached to the thin filament, is 15.6 nm (8, 9, 15) . For simplicity we define h ¼ 1 unit length ¼ 15.6 nm. We assume that an attached cross-bridge, independent of its phosphorylation state, generates a force that depends on its displacement. The total force generated by SMCs is proportional to the first moment of the AM and AM p distribution
Force balance
We assume that the SMCs are organized in a ring around an airway of radius R(t) and exert a tangential force. We also assume that this ring is embedded in a linearly elastic, isotropic homogeneous sheet, with the airway positioned at the center. For simplicity we assume radial symmetry and define the displacement u r ¼ R À R 0 , where R 0 is the radius at rest (i.e., when the SMCs are exerting no force). At all times we neglect inertia and assume that the force exerted by the SMCs is balanced by the force exerted by the elastic sheet; the balance of these forces determines the airway radius. Thus, the transient behavior exhibited by the contraction (as seen in Fig. 3 ) is due entirely to the cross-bridge kinetics.
For small displacements the components of the strain tensor are (16) 
Assuming Hooke's law for the elastic medium, the stress components are
and s ur ¼ s ru ¼ 0, where l and m are the two Lamé constants that characterize the elastic medium. If N c SMCs are arranged serially around an airway of radius, R, with each exerting a tangential force, F, the total radial force is N c F/R. Note that, as the radius increases, the total radial force decreases although the tangential force remains the same. Thus the boundary conditions for the stress are
In mechanical equilibrium, the equation for conservation of linear momentum is
Using Eqs. 9-11 we obtain
which, together with the boundary conditions Eq. 12, gives
Note that the displacement is now independent of the radius of the airway. The 1/R dependence in the expression for the radial strain cancels out with the radial dependence in the solution of the linear momentum equation. Although this is true for the simple radially symmetric case we consider here, it is not true in general for more complicated geometries. Similarly, this solution relies on the assumption of linear elasticity.
All results are given as relative area (i.e., fraction of airway (arteriole) area divided by the area at rest), which is determined by the balance between the tethering of the medium surrounding the airway and the force exerted by the SMCs. The radius at rest, R(0), is determined by the steady-state cross-bridge distribution at given initial agonist and calcium concentrations. The relative area is then R.
2 . Using Eqs. 8 and 15 and
where we introduced the dimensionless parameter b ¼ pk/(L 0 m).
Contraction velocity
As the airway radius changes, the velocity of the cross-bridges must also be calculated as a function of time, as the contraction velocity affects the force generated by the SMC. Isometric solutions are qualitatively different from the solutions shown here (computations not shown). We assume that each SMC contains N contractile units, arranged serially, and that each contractile unit contracts from both ends and therefore has a shortening velocity of 2hv(t). Thus the SMC has shortening velocity N2hv(t). Using Eq. 15, we obtain a relation between velocity and force
With Eq. 8 the velocity reads
Here we introduce the dimensionless parameter
The quantity L 0 /N corresponds approximately to the length of a contractile unit. Integration by parts gives a formula to compute the velocity
Note that this computation of the contraction velocity relies on the assumption that the force exerted by the SMCs is exactly balanced by the surrounding elastic sheet (Eq. 15). Thus, the solution procedure is as follows: for a given calcium concentration we substitute the expression for the contraction velocity (Eq. 19) into the cross-bridge partial differential equations, solve numerically (using a midpoint implicit upwind scheme, as described in the Appendix), and thus calculate the force generated by the SMCs. The change in radius is then calculated from the force balance equation (Eqs. 15 and 16).
RESULTS
Model parameters are listed in Table 1 In response to a step increase in [Ca 21 ] i (Figs. 1 and 3) , the airway initially contracts (because MLCK activity quickly increases) but subsequently slowly relaxes (because MLCP activity slowly increases) (Fig. 3, A and B) . The model predicts that during this transient contraction the contractile force arises mainly from cross-bridges in the latch state. The initial phosphorylation of myosin allows binding to actin, and there is a small transient increase in AM p . However, myosin quickly moves into the latch state (AM) as soon as MLCP activity begins to increase (Fig. 3 C) . Due to the depletion of the phosphorylated myosin (M p ), a contraction cannot be maintained and the subsequent relaxation of the airway correlates with the slow dissociation of the latch state from actin.
The second step increase in [Ca 21 ] i (to 1.3 mM) induces a smaller contractile response (Fig. 3 A) . This is consistent with the fact that the airway SMC has adapted to the elevated [Ca 21 ] i by increasing MLCP activity. In addition, the contractile effect of the additional activation of MLCK by the step increase of Ca 21 is mitigated by the increased MLCP activity (Fig. 3 B) . The step increase in Ca 21 also further activates the MLCP, and over time the airway relaxes again but to a level determined by the new equilibrium resulting from the high activity of both MLCK and MLCP. Furthermore, as shown in Fig. 6 , if the airway has not been previously adapted to high [Ca 21 ] i , the contractile response to the same increase in [Ca 21 ] i (1.3 mM) is considerably stronger (compare Fig. 6 to Figs. 1 and 3) .
A step decrease in Ca 21 serves to relax the airway rapidly as the MLCK activity falls in the presence of high MLCP activity. However, the subsequent addition of agonist stimulates a substantial airway contraction, often equal to that observed in normal lung slices. Because the [Ca 21 ] i is still high and does not change upon agonist addition, this response is explained by the agonist inducing a rapid decrease in the MLCP activity: the agonist is working by turning off the MLCP (the ''off'' or relaxation process) rather than by turning on the MLCK (the ''on'' or contractile process). The values either were determined by fitting to data or were taken from Mijailovich et al. (8) . The 95% confidence intervals are obtained from MCMC (see Appendix).
Consequently, the amount of phosphorylated myosin increases. At high agonist concentrations, the model predicts that both AM p and AM contribute to the contraction (Fig. 3  C) . Finally, when the agonist is removed, the MLCK activity quickly decreases, whereas the MLCP activity remains high. This results in a fast decrease in the amount of phosphorylated myosin and a transient increase in latch-bridge formation (AM). Because unphosphorylated myosin can only dissociate from actin, the latch state dissociates to allow the airway to relax completely. Under conditions in which the [Ca 21 ] i remains constant, the airway SMCs respond to increasing concentrations of agonist by step increases in contraction (Fig. 4 A) . It is important to note that at the beginning of this experiment, the airway is fully relaxed because the airway has been previously exposed to high [Ca 21 ] i for an extended period: both the MLCP and MLCK are active before the addition of agonist. The increased contraction is due to inactivation of MLCP (Fig. 4 B) . Consequently, the model predicts an increase in the amount of phosphorylated myosin as a function of agonist concentration (Fig. 4 C) .
A similar step increase in contraction occurs in response to step increases in [Ca 21 ] i when the agonist concentration is held constant (Fig. 5 A) . At the beginning of this experiment, the airway is also fully relaxed, but in this case the [Ca 21 ] i and agonist concentration were maintained low for an extended period. Consequently, the MLCK is inactive but the MLCP has residual activity (Fig. 5 B) . From these studies the model predicts an increase in the amount of phosphorylated myosin as a function of calcium concentration (Fig. 5 C) .
Arteriole MLCP is not regulated by calcium
We applied the same model to both airway and arteriole SMC. In fitting to the arteriole data of Figs. 6 and 7, six of the parameters (k 1b , k on2 , k off2 , t p , g 1 , andk 2 ) were changed. All other parameters were held fixed at the values obtained for airway SMC.
Airway SMCs and arteriole SMCs respond quite differently to a step increase in [Ca 21 ] i . In arteriole SMCs, the initial contraction occurs more slowly, and an adaptive relaxation does not occur (Fig. 6, upper panel) . Although kinase activity in both airway and arteriole SMCs increases (Fig. 6, lower panel) , arteriole phosphatase activity is independent of [Ca 21 ] i (low k on2 , Table 1 ). A subsequent increase in agonist concentration causes a stronger contraction (Fig. 7 A) , the result of a decrease in phosphatase activity (Fig. 7 B) . In arteriole, the initial Ca 21 -dependent contraction is maintained by the latch state AM, but the agonist-dependent contraction is maintained principally by phosphorylated myosin, AM p (Fig. 7 C) . Thus the model strongly suggests that, unlike airway SMCs, MLCP in arteriole SMCs is regulated by agonist but not by Ca 21 . In both airway and arteriole, relaxation after removal of Ca 21 or agonist is due to dissociation of the latch state from actin (Figs. 3 C, 4 C, 5 C, and 7 C). However, airway SMCs relax faster than arteriole SMCs. The model predicts that this difference is due to a slower dissociation of the latch state from actin in arteriole SMCs. We found that the dissociation rate constant g 1 in arteriole SMCs is ;4 times smaller than that in airway SMCs (Table 1) . To show this, we varied the frequency of the Ca 21 oscillations while maintaining the same average Ca 21 and agonist concentration (Fig. 8, A and B) . Because the average [Ca 21 ] i remains constant, the high-and low-frequency Ca 21 oscillations must necessarily have long and short spike durations, respectively (upper inset of Fig. 8 A) . In airway SMCs all Ca 21 oscillation frequencies cause a greater contraction than does a constant Ca 21 signal of the same average [Ca 21 ] i (Fig. 8 A) . For the arteriole this was true only for high-frequency oscillations (Fig. 8 B) . Although high-frequency oscillations gave greater contraction, frequencies above 5 spikes/min for the airway and 0.5 spikes/min for the arteriole cause little additional contraction. Experimentally, frequencies range from 5 to 25 spikes/min for the airway and from 0.5 to 6 spikes/min for the arteriole (3, 4) . This means that the Ca 21 oscillation frequencies observed in vivo are optimized toward strong contraction.
Response to calcium oscillations
In vivo the average [Ca 21 ] i will also vary with agonist. We therefore calculated, across a range of values for average [Ca 21 ] i , the extent of contraction for low-frequency oscillations and for high-frequency oscillations (Fig. 8, C and D 21 ] i even at higher concentrations (Fig. 8, C and D) . In airway SMC, at all average [Ca 21 ] i , both low-frequency and highfrequency oscillations cause a greater contraction than does a constant [Ca 21 ] i (Fig. 8 C) . However, in arteriole SMC, lowfrequency oscillations always cause a lesser contraction than does a constant [Ca 21 ] i (Fig. 8 D) . Hence, the behavior seen in Fig. 8, A Similar results are obtained when the spike amplitude is increased (computations not shown).
Calcium oscillations can also be stimulated by KCl, but these oscillations are qualitatively different from those caused by agonist, having a much lower frequency of ;1 spike/min. It is observed experimentally that KCl-induced oscillations cause a smooth contraction of the arteriole but no coordinated contraction of the airway (3, 4) .
Our model provides a quantitative explanation of this observation, as illustrated in Fig. 9 . In the model, slow [Ca 21 ] i oscillations cause strong fluctuations in the airway SMC length but nearly no fluctuations for arteriole SMCs (Fig. 9 A) . The reason for this is that arteriole SMCs relax more slowly than airway SMCs (smaller g 1 , Table 1 ) and is thus better able to integrate the slow oscillations. For calcium oscillations with higher frequencies (.5 spikes/min), the fluctuations in the SMC length for both airway and arteriole are almost undetectable. The reason these length fluctuations remain small at high frequencies is that, according to our model, the kinetics of cross-bridge formation cannot closely follow the change in [Ca 21 ] i because the time required for MLCP activation and cross-bridge attachment/detachment is much longer than the period of the oscillations.
Because calcium oscillations are not synchronous between the cells of the airway or arteriole (3, 4) , the overall contraction is computed by taking the average over multiple SMCs (six for the airway, three for the arteriole); the overall changes in the area are smoother (Fig. 9 B) . As expected from the previous results, the response to a constant [Ca 21 ] i (Fig. 9 B, dashed line) is always less than the response to the oscillation.
DISCUSSION
Although the basic smooth muscle cross-bridge model based on actin and myosin interactions was established in 1988, our understanding of enzymes that regulate contraction remains largely incomplete. In particular, our understanding of MLCP and its biochemical pathways is rather limited in comparison to our understanding of MLCK. Our model suggests that in murine lung slices, both MLCK and MLCP are upregulated by Ca 21 , but because this activation occurs on different timescales, airway SMC contraction adapts to maintained increases in [Ca 21 ] i , first contracting and then relaxing. Just as importantly, agonists induce contraction in two ways: first, by activating the ''on'' step (increased MLCK activity), via an increase in [Ca 21 ] i , and second, by inactivating the ''off'' step (decreased MLCP activity). The implication of these results is that increases in [Ca 21 ] i alone are less effective in stimulating contraction and that MLCP must be inactivated by the agonist before significant contraction can occur (Fig. 3) .
The enhancement of Ca 21 sensitization by the inhibition of MLCP by agonist in detergent or toxin-permeabilized SMCs has been previously reported (14, (18) (19) (20) . MLCP activation causing relaxation of SMCs has been observed in cells with elevated cyclic GMP concentration (21) (22) (23) by KCl cause a smooth contraction in arteriole SMC but no coordinated contraction in airway SMC. It is interesting to note that, in vivo, calcium oscillations have higher frequencies in airway (5-25 spikes/min) than in arteriole (0.5-6 spikes/min). The model thus predicts that agonist-induced Ca 21 oscillations in both airway and arteriole are optimized for maximal contraction.
APPENDIX Parameter estimation
A midpoint implicit upwind method (28) was used to solve the model equations. We used a time step of Dt ¼ 100 ms and a space discretization of Dx ¼ 0.05h. A smaller time step or discretization did not improve the simulations. Parameter values involved in MLCK and MLCP activities and AM dissociation (Table 1) were determined for the airway by fitting the model to experimental data from Bai and Sanderson (5) Parameter values involved in the position-dependent attachment and detachment rates (Table 1) were taken from Mijailovich et al. (8) , with the exception of g 1 , the dissociation rate constant of the cross-bridges in the latch state, which was included in the fitting process. With the value given in Mijailovich et al. (8) , the AM cross-bridges would remain immobile in the latch state and the airway relaxation after agonist removal would be extremely slow. For b of Eq. 16, we take a value of 2. This allows complete contraction when all cross-bridges are attached to actin. The average length of a contractile unit in airway SMCs varies, and a range from 0.7 to 2.2 mm has been reported (29, 30) . We take L 0 /N ¼ 0.7 mm and obtain for the parameter rescaling the velocity g ¼ L 0 /(2Nh)b a value of 44.87.
Parameter fitting was done using a Bayesian Markov-Chain Monte Carlo (MCMC) approach. Briefly, we constructed the posterior distribution of the parameters p given the data d, Pr(pjd), by using the Bayesian formalism. Thus PrðpjdÞ;PrðdjpÞPrðpÞ:
Given a parameter set, we calculate the probability of the data given the parameters, Pr(djp), by solving the model equations numerically. We assume that the error at each data point is Gaussian distributed with variance (0.051) 2 ; this is approximately the variance (5.1%) observed between different lung slices (5) when the data are plotted as a relative area. We have
where d i is the computed approximation of the ith data point, d i the ith data point. The prior Pr(p) was chosen uniform for positive parameter values and 0 otherwise. MCMC sampling of the posterior distribution Pr(pjd) was done using a Metropolis-Hastings algorithm. 
